Informing Patients about Biosimilar Medicines: The Role of European Patient Associations

Biosimilar medicines support the sustainability of national healthcare systems, by reducing costs of biological therapies through increased competition. However, their adoption into clinical practice largely depends on the acceptance of healthcare providers and patients. Patients are different from...

Descripción completa

Detalles Bibliográficos
Autores principales: Vandenplas, Yannick, Simoens, Steven, Van Wilder, Philippe, Vulto, Arnold G., Huys, Isabelle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7913743/
https://www.ncbi.nlm.nih.gov/pubmed/33557030
http://dx.doi.org/10.3390/ph14020117

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7913743/
https://www.ncbi.nlm.nih.gov/pubmed/33557030
http://dx.doi.org/10.3390/ph14020117

Ejemplares similares